Cargando…
Introduction of glycated albumin measurement for all blood donors and the prevalence of a high glycated albumin level in Japan
(J Diabetes Invest, doi: 10.1111/j.2040‐1124.2012.00224.x, 2012) Aims/Introduction: The Japanese Red Cross Society introduced measurement of glycated albumin (GA) for all blood donors as a glycemic control marker. The GA levels were examined by sex and age. Materials and Methods: GA was measured i...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4015427/ https://www.ncbi.nlm.nih.gov/pubmed/24843613 http://dx.doi.org/10.1111/j.2040-1124.2012.00224.x |
_version_ | 1782315336338505728 |
---|---|
author | Araki, Takeshi Ishikawa, Yoshihide Okazaki, Hitoshi Tani, Yoshihiko Toyooka, Shigetake Satake, Masahiro Miwa, Umeo Tadokoro, Kenji |
author_facet | Araki, Takeshi Ishikawa, Yoshihide Okazaki, Hitoshi Tani, Yoshihiko Toyooka, Shigetake Satake, Masahiro Miwa, Umeo Tadokoro, Kenji |
author_sort | Araki, Takeshi |
collection | PubMed |
description | (J Diabetes Invest, doi: 10.1111/j.2040‐1124.2012.00224.x, 2012) Aims/Introduction: The Japanese Red Cross Society introduced measurement of glycated albumin (GA) for all blood donors as a glycemic control marker. The GA levels were examined by sex and age. Materials and Methods: GA was measured in 3.14 million blood donors who donated between April 2009 and March 2010. For the reference range for GA, values that were three times the reference range for glycated hemoglobin (Japan Diabetes Society value) were used. All donors were notified of their GA levels. For repeat donors, a comparison was made between the GA levels at the first and second donations to verify the GA change after notification. Results: The mean GA was significantly lower in males than in females in donors aged <60 years. The mean GAs of both sexes increased with age and reached the same level of 14.8% in their 60s. The percentage of donors with prediabetes/diabetes (GA ≥16.5%) was 2.8% in males and 2.3% in females. In the normal high group (15.6% ≤ GA < 16.5%), the mean GA at the second donation was lower by 0.20% than at the first donation. In 42.4% of these donors, GA decreased to the normal range at the second donation. Conclusions: Overall, 2.7% of otherwise healthy Japanese blood donors had a high GA (GA ≥16.5%). Donor blood screening for GA represents an effective measure to identify people at risk of diabetes. The decrease in the GA level after GA notification might indicate the potential usefulness of this strategy to improve glycemic control among people with high GA. |
format | Online Article Text |
id | pubmed-4015427 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Blackwell Publishing Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-40154272014-05-19 Introduction of glycated albumin measurement for all blood donors and the prevalence of a high glycated albumin level in Japan Araki, Takeshi Ishikawa, Yoshihide Okazaki, Hitoshi Tani, Yoshihiko Toyooka, Shigetake Satake, Masahiro Miwa, Umeo Tadokoro, Kenji J Diabetes Investig Articles (J Diabetes Invest, doi: 10.1111/j.2040‐1124.2012.00224.x, 2012) Aims/Introduction: The Japanese Red Cross Society introduced measurement of glycated albumin (GA) for all blood donors as a glycemic control marker. The GA levels were examined by sex and age. Materials and Methods: GA was measured in 3.14 million blood donors who donated between April 2009 and March 2010. For the reference range for GA, values that were three times the reference range for glycated hemoglobin (Japan Diabetes Society value) were used. All donors were notified of their GA levels. For repeat donors, a comparison was made between the GA levels at the first and second donations to verify the GA change after notification. Results: The mean GA was significantly lower in males than in females in donors aged <60 years. The mean GAs of both sexes increased with age and reached the same level of 14.8% in their 60s. The percentage of donors with prediabetes/diabetes (GA ≥16.5%) was 2.8% in males and 2.3% in females. In the normal high group (15.6% ≤ GA < 16.5%), the mean GA at the second donation was lower by 0.20% than at the first donation. In 42.4% of these donors, GA decreased to the normal range at the second donation. Conclusions: Overall, 2.7% of otherwise healthy Japanese blood donors had a high GA (GA ≥16.5%). Donor blood screening for GA represents an effective measure to identify people at risk of diabetes. The decrease in the GA level after GA notification might indicate the potential usefulness of this strategy to improve glycemic control among people with high GA. Blackwell Publishing Ltd 2012-06-26 2012-12-20 /pmc/articles/PMC4015427/ /pubmed/24843613 http://dx.doi.org/10.1111/j.2040-1124.2012.00224.x Text en © 2012 Asian Association for the Study of Diabetes and Wiley Publishing Asia Pty Ltd |
spellingShingle | Articles Araki, Takeshi Ishikawa, Yoshihide Okazaki, Hitoshi Tani, Yoshihiko Toyooka, Shigetake Satake, Masahiro Miwa, Umeo Tadokoro, Kenji Introduction of glycated albumin measurement for all blood donors and the prevalence of a high glycated albumin level in Japan |
title | Introduction of glycated albumin measurement for all blood donors and the prevalence of a high glycated albumin level in Japan |
title_full | Introduction of glycated albumin measurement for all blood donors and the prevalence of a high glycated albumin level in Japan |
title_fullStr | Introduction of glycated albumin measurement for all blood donors and the prevalence of a high glycated albumin level in Japan |
title_full_unstemmed | Introduction of glycated albumin measurement for all blood donors and the prevalence of a high glycated albumin level in Japan |
title_short | Introduction of glycated albumin measurement for all blood donors and the prevalence of a high glycated albumin level in Japan |
title_sort | introduction of glycated albumin measurement for all blood donors and the prevalence of a high glycated albumin level in japan |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4015427/ https://www.ncbi.nlm.nih.gov/pubmed/24843613 http://dx.doi.org/10.1111/j.2040-1124.2012.00224.x |
work_keys_str_mv | AT arakitakeshi introductionofglycatedalbuminmeasurementforallblooddonorsandtheprevalenceofahighglycatedalbuminlevelinjapan AT ishikawayoshihide introductionofglycatedalbuminmeasurementforallblooddonorsandtheprevalenceofahighglycatedalbuminlevelinjapan AT okazakihitoshi introductionofglycatedalbuminmeasurementforallblooddonorsandtheprevalenceofahighglycatedalbuminlevelinjapan AT taniyoshihiko introductionofglycatedalbuminmeasurementforallblooddonorsandtheprevalenceofahighglycatedalbuminlevelinjapan AT toyookashigetake introductionofglycatedalbuminmeasurementforallblooddonorsandtheprevalenceofahighglycatedalbuminlevelinjapan AT satakemasahiro introductionofglycatedalbuminmeasurementforallblooddonorsandtheprevalenceofahighglycatedalbuminlevelinjapan AT miwaumeo introductionofglycatedalbuminmeasurementforallblooddonorsandtheprevalenceofahighglycatedalbuminlevelinjapan AT tadokorokenji introductionofglycatedalbuminmeasurementforallblooddonorsandtheprevalenceofahighglycatedalbuminlevelinjapan AT introductionofglycatedalbuminmeasurementforallblooddonorsandtheprevalenceofahighglycatedalbuminlevelinjapan |